Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for SepsisChristopher Seymour, Derek C. Angus, Jason Kennedy et al.|JAMA|2019Cited by 1.5k
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.Sweta Chekuri, Aaron W. Aday, Farah Al-Beidh et al.|Bristol Research (University of Bristol)|2021Cited by 589
Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant SurgeDavid T. Huang, Christopher Seymour, Erin K McCreary et al.|JAMA Network Open|2022Cited by 54
Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19Erin K McCreary, Kevin E. Kip, J Ryan Bariola et al.|JAMA Network Open|2022Cited by 36
The comparative effectiveness of COVID-19 monoclonal antibodies: A learning health system randomized clinical trialErin K McCreary, David T. Huang, J Ryan Bariola et al.|Contemporary Clinical Trials|2022Cited by 26